2000
DOI: 10.1002/(sici)1096-9896(200003)190:4<495::aid-path535>3.0.co;2-t
|View full text |Cite
|
Sign up to set email alerts
|

Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
85
0
1

Year Published

2001
2001
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 137 publications
(88 citation statements)
references
References 27 publications
2
85
0
1
Order By: Relevance
“…This would delay the subsequent transfer of infectivity via peripheral nerves into the CNS (21). However, LT␤R treatment also significantly reduced disease susceptibility, suggesting a substantial portion of the inoculum is destroyed, for example, by macrophages (4,9). These data are congruent with the suggestion that the action of macrophages on TSE pathogenesis is dose dependent: small doses of infectivity may be easily destroyed by macrophages, whereas higher doses are less easily digested and a fraction is retained.…”
supporting
confidence: 63%
“…This would delay the subsequent transfer of infectivity via peripheral nerves into the CNS (21). However, LT␤R treatment also significantly reduced disease susceptibility, suggesting a substantial portion of the inoculum is destroyed, for example, by macrophages (4,9). These data are congruent with the suggestion that the action of macrophages on TSE pathogenesis is dose dependent: small doses of infectivity may be easily destroyed by macrophages, whereas higher doses are less easily digested and a fraction is retained.…”
supporting
confidence: 63%
“…[47][48][49][50] Hence, the more pronounced microgliosis in the IL-1RI Ϫ/Ϫ mice could be because of the reduced astrocytosis in these animals and possibly affects the deposition of PrP Sc by enhanced microglial phagocytosis of amyloid. [51][52][53][54] Our observations indicate that IL-1 acts as a driver of the scrapie-associated activation of astrocytes during early stages of the disease. Although IL-1 is clearly not essential for the development of the ultimately lethal neurodegeneration (Table 1), the experimental model suggests that therapeutic agents that suppress astrocyte activation and/or glial IL-1 expression may help to delay disease onset in established prion infections of the central nervous system.…”
Section: Discussionmentioning
confidence: 61%
“…43 Dendritic cells and macrophages in SED would immediately degrade incorporated PrP c . 44,45 These results indicate that the undigested PrP Sc may induce the accumulation of PrP-positive cells in the subfollicle region of Peyer's patches and their spread to the MLN and the spleen.…”
Section: Discussionmentioning
confidence: 84%
“…Additionally, the depletion of spleen macrophages by administrating clodronate to mice shows that macrophages partly control scrapie infection in peripheral tissues by sequestration of the scrapie inoculum and impairment of the replication of scrapie infectious agents in the spleen during the early stages of the disease. 45 DCs 49 and macrophages 50 in Peyer's patches were previously reported to express the CD11b molecule. In addition, it has also been reported that only DCs in Peyer's patches expressed annexin V. 27 PrP-positive cells in Peyer's patches did not express annexin V in our study ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%